Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
AnnouncementAnnouncement

ASPET Journals Support the National Institutes of Health Principles and Guidelines for Reporting Preclinical Research

Journal of Pharmacology and Experimental Therapeutics July 2015, 354 (1) 88-89; DOI: https://doi.org/10.1124/jpet.115.225995
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Over the last several years there has been growing concern within the biomedical research community regarding a common perception that the level of scientific reproducibility and self-correction in preclinical research is not adequate (Collins and Tabak, 2014). In one initiative to address this situation, the National Institutes of Health (NIH) in collaboration with Nature and Science/American Association for the Advancement of Science, held a workshop on June 14, 2014, for biomedical journal editors (including The Journal of Pharmacology and Experimental Therapeutics) that addressed the reproducibility and rigor of published research findings. Workshop attendees provided input to a draft set of methodological guidelines for published research. The ASPET Board of Publications Trustees reviewed the draft guidelines and submitted a response to the NIH on August 19, 2014.

On November 5, 2014, the National Institutes of Health announced “Principles and Guidelines for Reporting Preclinical Research” (http://www.nih.gov/about/reporting-preclinical-research.htm). The guidelines address five principle areas of concern for the publication of preclinical biologic research: rigorous statistical analysis, transparency in reporting, data and material sharing, consideration of refutations, and the establishment of best practice guidelines in the areas of image-based data and the description of biologic materials with enough information to uniquely identify the reagents (in particular, antibodies, cell lines, and animals).

ASPET publishes three primary research journals: The Journal of Pharmacology and Experimental Therapeutics (JPET; founded in 1909), Molecular Pharmacology (1965), and Drug Metabolism and Disposition (1973). ASPET also publishes a review journal, Pharmacological Reviews, established in 1949. It is the intent and mission of ASPET’s journals to hold to high standards of scientific rigor. Since their inception, ASPET’s primary research journals have placed no limit on the Materials and Methods section in each journal, allowing for detailed descriptions of experimental methodology. Critical evaluation of experimental design issues, statistical analyses, and the validation of reagents have also been key components of the peer-review process. Peer reviewers are evaluated by the editors-in-chief and associate editors on their attention to these issues. In recent years, ASPET’s Board of Publications Trustees has expanded and strengthened its reporting requirements. For instance, the chemical identity of novel research compounds must be provided, and the sex of experimental subjects must be noted for in vivo studies and studies using primary cultures of cells or tissues from animals or humans. The coordinates and structure factor amplitudes for studies, including crystallographic data, must be provided and deposited with the Protein Data Bank. The nomenclature used to identify receptors and ion channels should conform to the guidelines of the Committee on Receptor Nomenclature and Drug Classification of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), whose nomenclature reports are published in Pharmacological Reviews. Most recently, we eliminated limits on references.

Consistent with its history, ASPET strongly supports the NIH Principles and Guidelines for Reporting Preclinical Research. ASPET’s journals and over 70 other leading biomedical research journals have endorsed these guidelines (http://www.nih.gov/about/endorsing-jounals.htm). To further enhance support for the goals of the NIH guidelines and provide a higher level of transparency in the areas of experimental design, description of methods, and statistical analysis, ASPET has implemented the following editorial actions: With this issue, the JPET Web site has been updated with revised Instructions to Authors establishing the preferred standards for reporting of experimental design and methodology, and reporting requirements for randomization, blinding, normalization and statistical analyses, and reagent validation. Several excellent reviews, commentaries, and the references therein on key aspects of experimental design and statistical analysis have been recently published that authors and readers will find of value (Landis et al., 2012; Marino, 2014; Motulsky, 2014). The JPET Editorial Board will carefully review how authors have addressed these methodological parameters during the peer-review process for all future submissions to the journal in an effort to further enhance the scientific rigor and transparency of pharmacological research reported in JPET. These changes were developed by the Board of Publications Trustees working with the editors of the ASPET journals. We know that you, our readers and authors, are proud to join us in this goal of increased research quality and transparency.

ASPET Board of Publications Trustees

Mary Vore, Chair

Darrell Abernethy

Randy Hall

Michael Jarvis

Kathryn Meier

Edward Morgan

Kim Neve

David Sibley

Stephen Traynelis

Jeffrey Witkin

Judy Siuciak, ex officio

Rich Dodenhoff, Journals Director

Footnotes

  • dx.doi.org/10.1124/jpet.115.225995.

  • Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics

References

  1. ↵
    1. Collins FS and
    2. Tabak LA
    (2014) Policy: NIH plans to enhance reproducibility. Nature 505:612–613.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Landis SC,
    2. Amara SG,
    3. Asadullah K,
    4. Austin CP,
    5. Blumenstein R,
    6. Bradley EW,
    7. Crystal RG,
    8. Darnell RB,
    9. Ferrante RJ,
    10. Fillit H,
    11. et al.
    (2012) A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490:187–191.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Marino MJ
    (2014) The use and misuse of statistical methodologies in pharmacology research. Biochem Pharmacol 87:78–92.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Motulsky HJ
    (2014) Common misconceptions about data analysis and statistics. J Pharmacol Exp Ther 351:200–205.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 354 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 354, Issue 1
1 Jul 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
ASPET Journals Support the National Institutes of Health Principles and Guidelines for Reporting Preclinical Research
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
AnnouncementAnnouncement

ASPET Journals Support the National Institutes of Health Principles and Guidelines for Reporting Preclinical Research

Journal of Pharmacology and Experimental Therapeutics July 1, 2015, 354 (1) 88-89; DOI: https://doi.org/10.1124/jpet.115.225995

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
AnnouncementAnnouncement

ASPET Journals Support the National Institutes of Health Principles and Guidelines for Reporting Preclinical Research

Journal of Pharmacology and Experimental Therapeutics July 1, 2015, 354 (1) 88-89; DOI: https://doi.org/10.1124/jpet.115.225995
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Announcement - Incoming JPET Editor
  • Ken Tew Named Editor in Chief
Show more Announcement

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics